ALX Oncology Holdings Inc (ALXO): Depreciation & Amortization
$706.0K
Year ended 2025-12-31
$540.0K
Trailing 12 months to 2026-06-30
+27.3%
3-year compound annual growth
+28.4%
5-year compound annual growth
| Period ended | Depreciation & Amortization | Change YoY | Source filing |
|---|---|---|---|
| 2025-12-31 | $706.0K | -19.0% | 2026-03-09, From 2025-01-01 |
| 2024-12-31 | $872.0K | +4.3% | 2026-03-09, From 2024-01-01 |
| 2023-12-31 | $836.0K | +144.4% | 2026-03-09, From 2023-01-01 |
| 2022-12-31 | $342.0K | +570.6% | 2025-03-06, From 2022-01-01 |
| 2021-12-31 | $51.0K | -74.8% | 2024-03-07, From 2021-01-01 |
| 2020-12-31 | $202.0K | -52.9% | 2023-03-09, From 2020-01-01 |
| 2019-12-31 | $429.0K | -0.5% | 2022-02-28, From 2019-01-01 |
| 2018-12-31 | $431.0K | n/a | 2021-03-18, From 2018-01-01 |
Depreciation & Amortization at similar companies
| Company | Year ended | Depreciation & Amortization | Change YoY |
|---|---|---|---|
| ALX Oncology Holdings Inc (ALXO) | 2025-12-31 | $706.0K | -19.0% |
| Scynexis Inc (SCYX) | 2024-12-31 | $0 | -100.0% |
| Rani Therapeutics Holdings, Inc. (RANI) | 2025-12-31 | $900.0K | -12.5% |
| ProPhase Labs, Inc. (PRPH) | 2025-12-31 | $4.83M | -21.9% |
| Rockwell Medical, Inc. (RMTI) | 2025-12-31 | $2.19M | +0.6% |
| Bolt Biotherapeutics, Inc. (BOLT) | 2025-12-31 | $1.29M | -27.5% |
| Lifevantage Corp (LFVN) | 2026-06-30 | $2.77M | -12.1% |
| OnKure Therapeutics, Inc. (OKUR) | 2025-12-31 | $447.0K | -2.6% |
| Connect Biopharma Holdings Ltd (CNTB) | 2025-12-31 | $704.0K | +6.7% |
Compare ALXO, SCYX, RANI, PRPH side by side · Screen every company in Pharmaceutical Preparations ↗